These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 398712)

  • 21. Plasma volume in men with low-, normal- and high-renin essential hypertension.
    Krupa-Wojciechowska B; Leonowicz K; Wyrzykowski B; Leonowicz J
    Cor Vasa; 1978; 20(3):196-201. PubMed ID: 688756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 24. [Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].
    Gutiérrez Millet V; Casado Pérez S; Ruilope Urioste LM; Hernando Avendaño L
    Rev Clin Esp; 1975 Apr; 137(2):105-14. PubMed ID: 1144838
    [No Abstract]   [Full Text] [Related]  

  • 25. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD; Hesse CJ
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of renin levels on the treatment of essential hypertension with thiazide diuretics.
    Wyndham RN; Gimenez L; Walker WG; Whelton PK; Russell RP
    Arch Intern Med; 1987 Jun; 147(6):1021-5. PubMed ID: 3296978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observations of the role of body fluid volumes and plasma renin activity in the management of hypertension.
    Dorhout Mees EJ; Geyskes GG; Vos J; Boer P
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):335-46. PubMed ID: 1156038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in the renin dependency of blood pressure induced by volume depletion and/or propranolol therapy in hypertensive patients.
    Geyskes GG; Boer P; Vos J; Dorhout Mees EJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():189s-192s. PubMed ID: 1071604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of propranolol. Observations on predictability.
    Birkenhäger WH; Krauss XH; Schalekamp MA; Kolsters G; Kroon BJ
    Folia Med Neerl; 1971; 14(2):67-71. PubMed ID: 5559125
    [No Abstract]   [Full Text] [Related]  

  • 31. [Arterial hypertension. A new classification and therapy based on renin plasma activity].
    Luna RL; Carrasco RM
    Arq Bras Cardiol; 1975 Jun; 28(3):277-91. PubMed ID: 1180712
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of propranolol on the dynamic changes of plasma-renin-activity in essential arterial hypertension].
    Gragnoli G; Palazzuoli V; Tanganelli I; Favilli R
    Cardiol Prat; 1975; 26(1):11-7. PubMed ID: 1222397
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
    Leonetti G; Mayer G; Morganti A; Terzoli L; Zanchetti A; Bianchetti G; Di Salle E; Morselli PL; Chidsey CA
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):491-9. PubMed ID: 1056279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
    Zweifler A; Esler M
    Am J Cardiol; 1977 Jul; 40(1):105-9. PubMed ID: 879001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.
    Bühler FR; Laragh JH; Baer L; Vaughan ED; Brunner HR
    N Engl J Med; 1972 Dec; 287(24):1209-14. PubMed ID: 5084985
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
    Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
    Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy.
    Leenen FH; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1984 Jun; 17(6):745-52. PubMed ID: 6146329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One and three doses of propranolol a day in hypertension.
    van den Brink G; Boer P; van Asten P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1980 Jan; 27(1):9-15. PubMed ID: 7351121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.